Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
47%
Antihypertensive Agent
11%
Antiplatelet
11%
Antivitamin K
47%
Artery Lesion
23%
Atherosclerosis
11%
Atorvastatin
71%
Atrial Fibrillation
11%
Biological Marker
6%
Bleeding
17%
Brain Ischemia
23%
C Peptide
13%
Cardiovascular Risk
47%
Carotid Artery Obstruction
11%
Cerebrovascular Accident
47%
Circulating microRNA
47%
Clinical Study
11%
Combination Therapy
47%
Comorbidity
11%
Coronary Artery Disease
82%
Dabigatran
5%
Ezetimibe
60%
Heart Arrhythmia
5%
Heart Infarction
23%
Hypercholesterolemia
6%
Hypolipemia
54%
Inclisiran
97%
Infrared Spectroscopy
53%
Low Density Lipoprotein
23%
Low Density Lipoprotein Cholesterol
100%
Metabolic Syndrome X
6%
microRNA
20%
microRNA 126
40%
microRNA 155
47%
Mortality Rate
5%
Pharmacokinetics
5%
Proprotein Convertase 9
23%
Prospective Study
6%
Rivaroxaban
5%
Rosuvastatin
71%
Statin (Protein)
67%
Stenosis
23%
Triacylglycerol
13%
Warfarin
35%
Medicine and Dentistry
Antihypertensive Therapy
7%
Antiplatelet
7%
Apoplexy
46%
Artery Lesion
23%
Atherosclerosis
11%
Atorvastatin
23%
Atrial Fibrillation
47%
Cardiovascular System
95%
Cardioversion
47%
Carotid Artery Stenosis
7%
Carotid Artery Stenting
47%
Clinical Study
7%
Combination Therapy
47%
Comorbidity
7%
Coronary Artery
47%
Coronary Artery Disease
30%
Ezetimibe
51%
Gene Inactivation
47%
Hypercholesterolemia
6%
Infrared Spectroscopy
23%
Interventional Cardiology
47%
Intravascular Imaging
95%
Intravascular Ultrasound
35%
Low Density Lipoprotein Cholesterol
95%
Low-Density Lipoprotein
23%
Myocardial Infarction
25%
near Infrared Spectroscopy
91%
Percutaneous Coronary Intervention
21%
Proprotein Convertase 9
23%
Recurrence Risk
47%
Recurrent Disease
9%
Risk Stratification
11%
Sensitivity and Specificity
11%
Sinus Rhythm
14%
Statin
58%
Stenosis
23%
Study Participant
23%
Surgical Risk
7%
Transient Ischemic Attack
14%
Vulnerable Plaque
23%
Biochemistry, Genetics and Molecular Biology
Alanine
19%
Blood Level
6%
Blood Plasma
47%
Body Mass
13%
C-Peptide
42%
Cholesterol Blood Level
9%
Glomerulus Filtration
47%
Glucose Blood Level
19%
Impaired Glucose Tolerance
47%
Kidney Function
6%
Lipid
9%
MicroRNA
95%
Mir-126
78%
Mir-145
28%
MiR-155
85%
Prospective Study
6%
Transaminase
19%
Triglyceride
32%